The valley of death kills most sustainable materials between the lab and the factory. Ikigaia is the group built to carry them across — we connect and fund the ecosystem to start it, prove it on our own line, and engineer it to build. One partner, every stage.
Tell us where you are and what has to be solved. We outline the funding paths, validation route and production concept — free, no account.
Whatever you bring, we meet you where you are on the journey.
Most partners hand you a study. We hand you a funded plan, a proven process, and a running plant.
The world has no shortage of biobased breakthroughs — only of breakthroughs that survive the journey to scale. The crossing needs four things at once, and no single specialist carries them.
A lab result is not a production line. Without validation on real equipment, no buyer qualifies it and no investor backs it.
Turning a process into a costed, buildable plant is a discipline most material innovators don't hold in-house.
Capital waits for de-risked evidence; evidence waits for capital. Ventures stall in the gap between the two.
Even a proven material needs a route into a real supply chain — the mill, the converter, the brand that buys it.
Three capabilities that hand off cleanly across the scale-up journey, and one group that closes the loop. Where others cover a single step, we carry the work the whole way.
Turns an idea into a funded, connected, de-risked opportunity.
Proves the material on a real line before a euro of capital is committed.
Engineers, builds and commissions the plant that makes it real.
Group advisory and capital — the flywheel that turns success into the next crossing.
Wherever you are — a lab result, a pilot, or a plan to scale — the first step is small, gated, and priced to let you in.
Tell us the material and where it needs to get to. We come back with a scoping note and a realistic plan.
Under NDA · no commitmentWe validate it on our own pilot line at Lemi — gate by gate, so you pay as you prove and can stop after any gate.
Start at a startup's budgetWhen the evidence holds, we engineer the scale-up — full EPCM, concept to a running plant, and stay to performance.
One team, end to endThe same ladder for a first-time founder as for a €280M mill — you just start lower.
Regeneering and Loonshot run their own sites; Innovations works at the group level and is described just below. Each carries the Ikigaia name — step into any of them, or let the group route the whole journey.
We turn an idea into a funded, connected, de-risked opportunity — ecosystem strategy, EU consortium building, funding pipelines, and AI-assisted impact and market intelligence.
Our own precommercial pilot platform, built on a once-idled industrial site brought back to life. A full pulping-to-forming line and an in-house ISO/TAPPI lab — where a material is proven from bench to production line before a euro is committed.
The EPCM and scale-up partner for biobased, circular and energy-transition manufacturing — de-risking first-of-kind, small-to-mid-cap projects (<€50M) from concept to a running plant, and staying on site to performance.
The group parent: governance, group-level advisory, and the capital relationships that surface deal flow for the whole pipeline — so every pilot feeds a scale-up, and every win feeds the next.
Innovations is the group's ecosystem and capital capability. It doesn't run a separate site — it works here, at the start of the journey: finding the idea, building the consortium, securing the funding, and connecting the capital that lets Loonshot prove it and Regeneering build it.
Regional innovation platforms and TKI strategy — turning public ambition into a concrete, self-financing plan that industry and startups actually use.
Horizon Europe and national instruments, concept to submission — with real multi-partner consortium credibility behind the applications.
AI-assisted, evidence-first analysis of markets, feedstocks and policy — the rigour Regeneering brings to engineering, applied to the opportunity.
The bridge between de-risked evidence and the funds that back it — surfacing and qualifying deal flow across the whole group.
Across every engagement, the rule is the same: a claim only counts if it traces to a measurement.
Not advisors borrowing someone else's pilot. We prove what we design, on our own line at Lemi — then engineer it to scale.
Go / no-go milestones, paid as we prove. You can walk after any gate. De-risking, made honest — and affordable.
Every number traces to a source. Deliverables built to withstand a procurement lead, an investment committee, and the target's own engineers reading them at once.
Build once, ship once. A trial and a purchase order in place of a multi-year capital project. We reframe the problem so the decision gets smaller.
Everything we do answers one of three questions: does it work, can it be built, and is the decision defensible?
The constant isn't the material. The same method reaches from a founder's first gated pilot to a €280M mill, and from Finland to Latin America.
We bought a dead factory and brought it back to life.
Our pilot site at Lemi stands on a plant that had gone insolvent. We acquired the idled factory, rebuilt it, and turned it into the line where we now prove other people's materials before they scale. It's the whole thesis in one place — we don't just talk about crossing the valley of death. We did it ourselves, with a factory everyone else had written off.
To sustain life is the highest duty.
Ikigai is a reason for being; we turn it toward the living world it serves. We replace fossil materials and processes with biobased and circular ones — at industrial scale, with evidence and purpose. A dream without action stays unanswered.
A material, a process, an ecosystem, or a scale-up decision — tell us where it is and where it needs to get to. The Success Creator gives you an outline in a minute; we come back with a plan and the right part of the group to run it.